Genes2Me introduces Rapi-Q for detection of multiple diseases

10 October 2022 | News

Genes2Me Rapi-Q point of care RTPCR system provides a convenient format for highly sensitive and specific diseases

Gurugram-based startup Genes2Me has announced the launch of its Rapi-Q- Point of Care RT PCR solution for 1-8 samples, which is easy to use and gives faster results in less than 45 minutes.

Backed by a powerful software analysis function, this CE-IVD marked point-of-care (POC) solution delivers superior performance, high sensitivity, and stable detection. 

Rapi-Q point of care RT PCR has been approved by the Indian Council of Medical Research (ICMR) after stringent quality checks. This small, light, and easy-to-carry system can process upto 8 samples in a single run. Rapi-Q is ideal for detecting several diseases, including tuberculosis, HPV, 3H (HIV, HCV & HBV), tropical Fever & respiratory ailments.

It comprises an eight-well block design with four fluorescent channels. It can perform singleplex and multiplex for qualitative/ quantitative analysis, melting curve analysis, genotyping, etc. Since it is lightweight (less than 3 kg), it can be easily installed in places of mass testing. The test offers high sensitivity, accuracy and top-notch performance detecting various diseases. It is also compatible with 50+ lyophilized room temperature stable disease detection kits. This system provides automated analysis, interpretation and reports.




× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account